Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 921-930 of 9364

Page
per page
  1. Genistein
    A2198 Genistein
    Target: Estrogen and Related Receptors|PPAR|PTK
    Summary: ER agonist
      ≥13.5 mg/mL
  2. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  3. Letrozole
    A1307 Letrozole
    Target: Aromatases
    Summary: Non-steroidal aromatase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.265 mg/mL
  4. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  5. Ki8751
    A1821 Ki8751
    Target: VEGFR
    Summary: VEGFR-2 inhibitor,potent and selective
      ≥23.45 mg/mL
  6. Adapalene
    A1267 Adapalene
    Target: RARs
    Summary: RARβ and RARγ agonist
      insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL
  7. Doxazosin Mesylate
    A2884 Doxazosin Mesylate
    Summary: α1-adrenergic receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥13.69 mg/mL
  8. Celecoxib
    A1664 Celecoxib
    Target: COX
    Summary: Selective cyclooxygenase-2 (COX-2) inhibitor
  9. SL-327
    A1894 SL-327
     1 Citation
    Target: MEK
    Summary: Selective MEK1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.75 mg/mL
  10. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL

Items 921-930 of 9364

Page
per page